Abstract
The objective of this study was to investigate the prevalence of CRISPR/Cas systems in P. aeruginosa, isolated from a Greek hospital. Additionally, we aimed to determine the origin of the sequenced spacers. A collection of 100 nonrepetitive P. aeruginosa was analyzed. Isolates were typed by MLST. The presence of CRISPR/Cas systems, as well as amplification of CRISPR arrays, was examined by PCR using specific primers. CRISPR/Cas systems were detected in 36 isolates, of which 27 isolates exhibited resistance to carbapenems, with 10 of the later isolates producing a VIM-type MβL. The majority (n = 19) of CRISPR/Cas-positive isolates harbored a type I–F system, while I–C and I–E systems were found in 9 and 8 isolates, respectively. Based on MLST, isolates carrying I–E and I–F systems belonged to different STs and included CRISPR arrays with diverse number of spacers. Isolates with I–C systems belonged to clonal complex 235 and exhibited identical CRISPR arrays. Among 425 unique spacers, identified during this study, BLASTn search showed that they matched with P. aeruginosa chromosomal sequences (47.0%), phages (31.9%), plasmids, PAGIs, and an ICE. 16.3% of the spacers exhibited no significant similarity with sequences submitted to GenBank database. In conclusion, we observed the presence of type I–C, I–E and I–F CRISPR/Cas systems in P. aeruginosa of clinical origin. CRISPR/Cas were also observed among isolates carrying the carbapenemase-encoding blaVIM gene, which is usually associated with integrons, questioning the defense role against mobile elements. Therefore, further experimental characterization is needed to clarify their functional role.
Similar content being viewed by others
References
Andrade SS, Jones RN, Gales AC, Sader HS (2003) Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997–2001). J Antimicrob Chemother 52:140–141. https://doi.org/10.1093/jac/dkg270
Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P (2007) CRISPR provides acquired resistance against viruses in prokaryotes. Science 315:1709–1712. https://doi.org/10.1126/science.1138140
Battle SE, Rello J, Hauser AR (2009) Genomic islands of Pseudomonas aeruginosa. FEMS Microbiol Lett 290:70–78. https://doi.org/10.1111/2Fj.1574-6968.2008.01406.x
Bolotin A, Quinquis B, Sorokin A, Ehrlich SD (2005) Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology 2005(151):2551–2561. https://doi.org/10.1099/mic.0.28048-0
Choi KR, Lee SY (2016) CRISPR technologies for bacterial systems: current achievements and future directions. Biotechnol Adv 34:1180–1209. https://doi.org/10.1016/j.biotechadv.2016.08.002
Cornaglia G, Giamarellou H, Rossolini GM (2011) Metallo-β-lactamases: a last frontier for β-lactams? Lancet Infect Dis 11:381–393. https://doi.org/10.1016/S1473-3099(11)70056-1
Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG (2004) Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J Clin Microbiol 42:5644–5649. https://doi.org/10.1128/JCM.42.12.5644-5649.2004
Essoh C, Blouin Y, Loukou G, Cablanmian A, Lathro S, Kutter E, Thien HV, Vergnaud G, Pourcel C (2013) The susceptibility of Pseudomonas aeruginosa strains from cystic fibrosis patients to bacteriophages. PLoS ONE 8:e60575. https://doi.org/10.1371/journal.pone.0060575
Hatoum-Aslan A, Marraffini LA (2014) Impact of CRISPR immunity on the emergence and virulence of bacterial pathogens. Curr Opin Microbiol 17:82–90. https://doi.org/10.1016/j.mib.2013.12.001
Ishino Y, Shinagawa H, Makino K, Amemura M, Nakata A (1987) Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol 169:5429–5433. https://doi.org/10.1128/jb.169.12.5429-5433.1987
Jansen R, Embden JD, Gaastra W, Schouls LM (2002) Identification of genes that are associated with DNA repeats in prokaryotes. Mol Microbiol 43:1565–1575. https://doi.org/10.1046/j.1365-2958.2002.02839.x
Luz ACO, da Silva JMA, Rezende AM, de Barros MPS, Leal-Balbino TC (2019) Analysis of direct repeats and spacers of CRISPR/Cas systems type I-F in Brazilian clinical strains of Pseudomonas aeruginosa. Mol Genet Genomics 294:1095–1105. https://doi.org/10.1007/s00438-019-01575-7
Luz ACO, da Silva WJ, do Nascimento JB, da Silva JMA, de Queiroz BV, Leal-Balbino TC (2021) Genetic characteristics and phylogenetic analysis of Brazilian clinical strains of Pseudomonas aeruginosa harboring CRISPR/Cas systems. Curr Genet 67:663–672. https://doi.org/10.1007/s00294-021-01173-4
Makarova KS, Wolf YI, Alkhnbashi OS, Costa F, Shah SA, SaundersSJ BR, Brouns SJ, Charpentier E, Haft DH, Horvath P, Moineau S, Mojica FJ, Terns RM, Terns MP, White MF, Yakunin AF, Garrett RA, van der Oost J, Backofen R, Koonin EV (2015) An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol 13:722–736. https://doi.org/10.1038/nrmicro3569
Mojica FJ, Diez-Villasenor C, Soria E, Juez G (2000) Biological significance of a family of regularly spaced repeats in the genomes of Archaea, Bacteria and mitochondria. Mol Microbiol 36:244–246. https://doi.org/10.1046/j.1365-2958.2000.01838.x
Mojica FJ, Diez-Villasenor C, Garcia-Martinez J, Soria E (2005) Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol 60:174–182. https://doi.org/10.1007/s00239-004-0046-3
Nakayama K, Kanaya S, Ohnishi M, Terawaki Y, Hayashi T (1999) The complete nucleotide sequence of phi CTX, a cytotoxin-converting phage of Pseudomonas aeruginosa: implications for phage evolution and horizontal gene transfer via bacteriophages. Mol Microbiol 31:399–419. https://doi.org/10.1046/j.1365-2958.1999.01158.x
Papagiannitsis CC, Medvecky M, Chudejova K, Skalova A, Rotova V, Spanelova P, Jakubu V, Zemlickova H, Hrabak J (2017) Molecular characterization of carbapenemase-producing Pseudomonas aeruginosa of Czech origin and evidence for clonal spread of extensively resistant Sequence Type 357 expressing IMP-7 metallo-β-lactamase. Antimicrob Agents Chemother 61:e01811-e1817. https://doi.org/10.1128/aac.01811-17
Papagiannitsis CC, Verra A, Galani V, Xitsas S, Bitar I, Hrabak J, Petinaki E (2020) Unravelling the features of success of VIM-Producing ST111 and ST235 Pseudomonas aeruginosa in a Greek hospital. Microorganisms 8:1884. https://doi.org/10.3390/microorganisms8121884
Perčulija V, Lin J, Zhang B, Ouyang S (2021) Functional features and current applications of the RNA-targeting type VI CRISPR-Cas systems. Adv Sci (Weinh) 8:2004685. https://doi.org/10.1002/advs.202004685
Pourcel C, Salvignol G, Vergnaud G (2005) CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology 151:653–663. https://doi.org/10.1099/mic.0.27437-0
Samuelsen O, Toleman MA, Sundsfjord A, Rydberg J, Leegaard TM, Walder M, Lia A, Ranheim TE, Rajendra Y, Hermansen NO, Walsh TR, Giske CG (2010) Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion. Antimicrob Agents Chemother 54:346–52. https://doi.org/10.1128/2FAAC.00824-09
Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL (2012) Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 25:682–707. https://doi.org/10.1128/CMR.05035-11
van Belkum A, Soriaga LB, LaFave MC, Akella S, Veyrieras JB, Barbu EM, Shortridge D, Blanc B, Hannum G, Zambardi G, Miller K, Enright MC, Mugnier N, Brami D, Schicklin S, Felderman M, Schwartz AS, Richardson TH, Peterson TC, Hubby B, Cady KC (2015) Phylogenetic distribution of CRISPR-Cas systems in antibiotic-resistant Pseudomonas aeruginosa. mBio 6:1796–15. https://doi.org/10.1128/mBio.01796-15
Wayne PA (2013) Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; CLSI 2013, 23rd International Supplement, CLSI document M100-S23. Clinical and Laboratory Standards Institute, Wayne, PA, USA
Funding
This work was supported by funding from the Research Committee of the University of Thessaly.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None declared.
Ethical approval
Not required.
Additional information
Communicated by Martine Collart.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gagaletsios, L.A., Papagiannitsis, C.C. & Petinaki, E. Prevalence and analysis of CRISPR/Cas systems in Pseudomonas aeruginosa isolates from Greece. Mol Genet Genomics 297, 1767–1776 (2022). https://doi.org/10.1007/s00438-022-01957-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00438-022-01957-4